H. Belabed

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α

B. Kuster, Roger L. Williams, G. Médard, 2022, Nature Chemical Biology.

Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model

V. Haucke, J. Laporte, M. Nazaré, 2022, Proceedings of the National Academy of Sciences of the United States of America.

An LPAR5-antagonist that reduces nociception and increases pruriception

R. O. Oude Elferink, J. Chichorro, Jens Schoene, 2022, Frontiers in Pain Research.

A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels

B. L. de Groot, B. Fakler, E. Carpenter, 2019, Science.

Phosphoinositide Conversion Inactivates R‐RAS and Drives Metastases in Breast Cancer

V. Haucke, E. Hirsch, P. P. Di Fiore, 2022, Advanced science.

Advancing ASMS with LC‐MS/MS for the discovery of novel PDCL2 ligands from DNA‐encoded chemical library selections

D. Young, M. Matzuk, M. Palaniappan, 2022, Andrology.

A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels

B. L. de Groot, B. Fakler, E. Carpenter, 2019, Science.